Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of triamcinolone and bleomycin on burn wounds
IRCT20120410009431N4Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of triamcinolone and bleomycin in burn injury (2 arms), sponsored by Iran University of Medical Sciences. Started Dec 2022; status: completed.
02
Drugs
triamcinolonebleomycin
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20120410009431N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120410009431N4.